Hypoxia-inducible factor-1 is a positive regulator of Sox9 activity in femoral head osteonecrosis

Bone

Volumn 48, Issue 3, 2011, Pages 507-513

  Zhang, Chi ^a,b   Yang, Fan ^a   Cornelia, Reuel ^a   Tang, Wanjin ^a   Swisher, Susanne ^a   Kim, Harry ^a,b  

^a TEXAS SCOTTISH RITE HOSPITAL FOR CHILDREN   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Cartilage; Femoral head osteonecrosis; Hypoxia inducible factor 1; Ischemia; Sox9

Indexed keywords

AGGRECAN; COLLAGEN TYPE 3; HYPOXIA INDUCIBLE FACTOR 1; TRANSCRIPTION FACTOR SOX9;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE RADIOGRAPHY; CARTILAGE CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; FEMUR HEAD NECROSIS; GENE EXPRESSION PROFILING; GENE INTERACTION; GENE TARGETING; GENETIC TRANSFECTION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MICROARRAY ANALYSIS; NONHUMAN; PROMOTER REGION; QUANTITATIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SWINE; TRANSCRIPTION INITIATION; UPREGULATION;

ANIMALS; ANOXIA; CARTILAGE; CELL DIFFERENTIATION; CERCOPITHECUS AETHIOPS; CHONDROCYTES; COS CELLS; FEMUR HEAD; FEMUR HEAD NECROSIS; GENE EXPRESSION REGULATION; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; PROTEIN BINDING; RATS; RNA, MESSENGER; SOX9 TRANSCRIPTION FACTOR; SUS SCROFA; TRANSCRIPTION, GENETIC;

EID: 79751529772     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2010.10.006     Document Type: Article

References (20)

1. Molloy M.K., MacMahon B. Incidence of Legg-Perthes disease (osteochondritis deformans). N Engl J Med 1966, 275:988-990.
2. Glimcher M.J., Kenzora J.E. The biology of osteonecrosis of the human femoral head and its clinical implications. III. Discussion of the etiology and genesis of the pathological sequelae; commments on treatment. Clin Orthop Relat Res 1979, 273-312.
3. Kim H.K., Su P.H. Development of flattening and apparent fragmentation following ischemic necrosis of the capital femoral epiphysis in a piglet model. J Bone Joint Surg Am 2002, 84-A:1329-1334.
4. Kim H.K., Su P.H., Qiu Y.S. Histopathologic changes in growth-plate cartilage following ischemic necrosis of the capital femoral epiphysis. An experimental investigation in immature pigs. J Bone Joint Surg Am 2001, 83-A:688-697.
5. Kim H.K., Bian H., Randall T., Garces A., Gerstenfeld L.C., Einhorn T.A. Increased VEGF expression in the epiphyseal cartilage after ischemic necrosis of the capital femoral epiphysis. J Bone Miner Res 2004, 19:2041-2048.
6. Provot S., Schipani E. Fetal growth plate: a developmental model of cellular adaptation to hypoxia. Ann NY Acad Sci 2007, 1117:26-39.
7. Giaccia A.J., Simon M.C., Johnson R. The biology of hypoxia: the role of oxygen sensing in development, normal function, and disease. Genes Dev 2004, 18:2183-2194.
8. Schipani E., Ryan H.E., Didrickson S., Kobayashi T., Knight M., Johnson R.S. Hypoxia in cartilage: HIF-1alpha is essential for chondrocyte growth arrest and survival. Genes Dev 2001, 15:2865-2876.
9. Pfander D., Cramer T., Schipani E., Johnson R.S. HIF-1alpha controls extracellular matrix synthesis by epiphyseal chondrocytes. J Cell Sci 2003, 116:1819-1826.
10. Zhao Q., Eberspaecher H., Lefebvre V., De Crombrugghe B. Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev Dyn 1997, 209:377-386.
11. Bi W., Deng J.M., Zhang Z., Behringer R.R., de Crombrugghe B. Sox9 is required for cartilage formation. Nat Genet 1999, 22:85-89.
12. Lefebvre V., Huang W., Harley V.R., Goodfellow P.N., de Crombrugghe B. SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol 1997, 17:2336-2346.
13. Kim H.K., Bian H., Aya-ay J., Garces A., Morgan E.F., Gilbert S.R. Hypoxia and HIF-1alpha expression in the epiphyseal cartilage following ischemic injury to the immature femoral head. Bone 2009, 45:280-288.
14. Zhang C., Cho K., Huang Y., Lyons J.P., Zhou X., Sinha K., et al. Inhibition of Wnt signaling by the osteoblast-specific transcription factor Osterix. Proc Natl Acad Sci USA 2008, 105:6936-6941.
15. Mabjeesh N.J., Escuin D., LaVallee T.M., Pribluda V.S., Swartz G.M., Johnson M.S., et al. 2ME2 inhibits tumor growth and angiogenesis by disrupting microtubules and dysregulating HIF. Cancer Cell 2003, 3:363-375.
16. Sekiya I., Tsuji K., Koopman P., Watanabe H., Yamada Y., Shinomiya K., et al. SOX9 enhances aggrecan gene promoter/enhancer activity and is up-regulated by retinoic acid in a cartilage-derived cell line, TC6. J Biol Chem 2000, 275:10738-10744.
17. Hirao M., Tamai N., Tsumaki N., Yoshikawa H., Myoui A. Oxygen tension regulates chondrocyte differentiation and function during endochondral ossification. J Biol Chem 2006, 281:31079-31092.
18. Provot S., Zinyk D., Gunes Y., Kathri R., Le Q., Kronenberg H.M., et al. Hif-1alpha regulates differentiation of limb bud mesenchyme and joint development. J Cell Biol 2007, 177:451-464.
19. Robins J.C., Akeno N., Mukherjee A., Dalal R.R., Aronow B.J., Koopman P., et al. Hypoxia induces chondrocyte-specific gene expression in mesenchymal cells in association with transcriptional activation of Sox9. Bone 2005, 37:313-322.
20. McAndrew M.P., Weinstein S.L. A long-term follow-up of Legg-Calve-Perthes disease. J Bone Joint Surg Am 1984, 66:860-869.